The clinical efficacy and effectiveness of the Lu-177 DOTATATE therapy

被引：0
|
作者：
Acar, E. [1 ]
Durak, H. [1 ]
Kaya, G. Capa [1 ]
机构：
[1] Dokuz Eylul Univ, Sch Med, Dept Nucl Med, Izmir, Turkey
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P797
引用
收藏
页码：S723 / S723
页数：1
相关论文
共 50 条
  • [21] ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy
    Love, Charito
    Desai, Neil B.
    Abraham, Tony
    Banks, Kevin P.
    Bodei, Lisa
    Boike, Thomas
    Brown, Richard K. J.
    Bushnell, David L.
    DeBlanche, Lorraine E.
    Dominello, Michael M.
    Francis, Tony
    Grady, Erin C.
    Hobbs, Robert F.
    Hope, Thomas A.
    Kempf, Jeffrey S.
    Pryma, Daniel A.
    Rule, William
    Savir-Baruch, Bital
    Sethi, Ila
    Subramaniam, Rathan M.
    Xiao, Ying
    Schechter, Naomi R.
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (06) : 503 - 511
  • [22] Optimisation of Lu-177 therapy administration
    Fernandez, R.
    Rai, S.
    Perry, A.
    Johnson, J.
    Croasdale, P.
    Eftychiou, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S661 - S662
  • [23] RELATIONSHIP BETWEEN WHOLE BODY CLEARANCE, KIDNEY DOSE AND GFR IN [LU-177]-DOTATATE THERAPY
    Hennessy, T.
    Bailey, D.
    Willowson, K.
    Chan, D.
    Pavlakis, N.
    Schembri, G.
    Roach, P.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 18 - 19
  • [24] Evaluation of thyroid function in patients receiving Lu-177 DOTATATE treatment
    Kibar, A.
    Ince, B.
    Nazari, A.
    Toplutas, K. N.
    Bilgic, S.
    Asa, S.
    Besli, R. L. Uslu
    Sager, M. S.
    Sayman, H. B.
    Sonmezoglu, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S470 - S470
  • [25] Peptide Receptor Radionuclide Therapy with Lu-177 DOTATATE in patients with somatostatin receptor positive tumours
    Kamaleshwaran, K.
    Sudhakar, N.
    Paulvannan, S.
    Vysakh, M.
    Shinto, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S722 - S722
  • [26] EFFICACY OF 177LU-DOTATATE THERAPY IN RECURRENT ANAPLASTIC MENINGIOMA
    Kizilbash, Sani
    Johnson, Derek
    NEURO-ONCOLOGY, 2019, 21 : 140 - 140
  • [27] Lu-177 DOTATATE dosimetry for neuroendocrine tumor: single center experience
    Said, M. A.
    Masud, M. A.
    Zaini, M. Z.
    Salleh, R. A.
    Lee, B. N.
    Zainon, R.
    10TH INTERNATIONAL SEMINAR ON MEDICAL PHYSICS & 1ST AMDI INTERNATIONAL ONCOLOGY SYMPOSIUM, 2017, 851
  • [28] Efficacy and Toxicity of Lu-177 DOTATATE in Well-Differentiated Grade 3a Neuroendocrine Tumours
    Santillan, N.
    Ferreira, B.
    Gnanasegaran, G.
    Navalkisoor, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S756 - S757
  • [29] A Personalized Remote Radiation-Tracking Vest for At-Home Monitoring of LU-177 DOTATATE Therapy
    Pierce, Larry
    Harrison, Robert
    Vesselle, Hubert
    Miyaoka, Robert
    PANCREAS, 2020, 49 (03) : 483 - 483
  • [30] Assessment of Thyroid and Breast Radiation Absorbed Doses in Lu-177 DOTATATE Therapy Using Voxel Dosimetry
    Alandnosi, Fyrooz
    Alrasheedi, Mohammed
    Brady, Amy
    George, Remo
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
12345